Director Michael J. Fox resigns from Cue Biopharma board effective Aug 28, 2024

Cue Biopharma, Inc.

Michael J. Fox resigned as director and from all board committees on August 28, 2024.
Resignation not related to any disagreement with the company on operations, policies, or practices.
No replacement director has been announced or named in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael J. Fox

Director

CUE · Cue Biopharma, Inc.

Effective: 2024-08-28
Filed: September 3, 2024, 7:59 PM ET

On August 28, 2024, Michael J. Fox notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective on August 28, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael J. Fox resigned as Director at Cue Biopharma, Inc..

Action: resigned
Role: Director

Exact text from the filing

On August 28, 2024, Michael J. Fox notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective on August 28, 2024.

View on SEC.gov

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-102851

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.